A path to improved pharmaceutical productivity

被引:9
作者
Cohen, CM
机构
[1] provides consultation to the biotechnology industry on organizational and technical matters,
关键词
D O I
10.1038/nrd1180
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The current use of metrics-driven approaches to improve the productivity of pharmaceutical drug discovery will fail. This article presents an approach to the use of performance metrics that has the potential to guide fundamental industry improvement though cooperation.
引用
收藏
页码:751 / 753
页数:3
相关论文
共 9 条
[1]  
*BOST CONS GROUP, 2001, REV R D GEN GEN TRAN
[2]  
*CHI, 2003, CHI STRAT OPT R D PE
[3]   The value of improving the productivity of the drug development process - Faster times and better decisions [J].
DiMasi, JA .
PHARMACOECONOMICS, 2002, 20 (Suppl 3) :1-10
[4]   Returns on research and development for 1990s new drug introductions [J].
Grabowski, H ;
Vernon, J ;
DiMasi, JA .
PHARMACOECONOMICS, 2002, 20 (Suppl 3) :11-29
[5]  
*IBC, 2003, IBC DRUG DISC TECHN
[6]  
*IBM BUS CONS SERV, 2002, PHARM 2010 THRESH IN
[7]  
*PAR INT, 2003, PAR PHARM R D STAT S
[8]  
*PHAC INC, 2003, R D LEAD FOR OCT GEN
[9]  
SIM P, 2003, J RESULTS 2002 DRUG